ED50< 0.5 xg/mL, measured by the FLIPR assay using CHO cells transfected with human CCR5, the receptor of human CCL8, corresponding to a specific activity of > 2 x 10^3 units/mg.
CCL8
Origine: Souris
Hôte: Escherichia coli (E. coli)
> 97 % by SDS-PAGE and HPLC analyses.
Active
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Reconstituted in ddH2O at 100 μg/mL.
Buffer
Lyophilized after extensive dialysis against PBS.
Stock
-80 °C
Stockage commentaire
Lyophilized recombinant human MCP-2/CCL8(rhMCP-2) remains stable up to 6 months at -80 °C from date of receipt. Upon reconstitution, rhMCP-2 remains stable up to 2 weeks at 4 °C or up to 3 months at -20 °C.
MCP-2 is a member of the chemokines, a group of 70-80 residue proteins sharing substantial sequence similarity. Within the chemokines, MCP-2 belongs to the CC subfamily, and is a member of the Monocyte Chemoattractant Proteins (MCPs), which includes MCP-1, MCP-2, MCP-3, MCP-4, and MCP-5. MCP-2 shares 60 % homology with MCP-1, and both proteins can undergo reversible dimerization. The main receptors of MCP-2 are G-protein coupled receptors CCR1 and CCR5. MCP-2 is a potential target in HIV-1 infected human glial cells as it may play a role in the modulation of viral spread in the brain. Recently, researchers found that mouse MCP-2 is expressed in the skin as a novel agonist of CCR8 and plays a role in eosinophilic inflammation.Recombinant human MCP-2/CCL8(rhMCP-2) produced in E. coli is a single non-glycosylated polypeptide chain containing 76 amino acids. A fully biologically active molecule, rhMCP-2 has a molecular mass of 8.9 kDa analyzed by reducing SDS-PAGE. Synonyms: Monocyte Chemoattractant Protein-2, HC14, SCYA8